Shares of Viveve Medical Inc (NASDAQ:VIVE) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $0.87 and last traded at $0.87, with a volume of 167739 shares changing hands. The stock had previously closed at $0.90.

A number of research firms recently issued reports on VIVE. Raymond James lowered their target price on Viveve Medical from $4.50 to $3.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 12th. Craig Hallum set a $1.00 target price on Viveve Medical and gave the company a “hold” rating in a research report on Friday, January 18th. Finally, Maxim Group reaffirmed a “buy” rating on shares of Viveve Medical in a research report on Thursday, January 17th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $5.20.

The company has a quick ratio of 3.20, a current ratio of 3.72 and a debt-to-equity ratio of 3.42. The stock has a market cap of $28.70 million, a PE ratio of -0.41 and a beta of 0.71.

A number of institutional investors have recently bought and sold shares of VIVE. Nantahala Capital Management LLC grew its holdings in Viveve Medical by 66.7% during the fourth quarter. Nantahala Capital Management LLC now owns 6,581,465 shares of the company’s stock worth $6,911,000 after purchasing an additional 2,633,333 shares during the period. RTW Investments LP grew its holdings in Viveve Medical by 42.4% during the fourth quarter. RTW Investments LP now owns 4,480,565 shares of the company’s stock worth $4,705,000 after purchasing an additional 1,333,333 shares during the period. Bank of New York Mellon Corp grew its holdings in Viveve Medical by 266.6% during the fourth quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock worth $47,000 after purchasing an additional 32,888 shares during the period. Sargent Investment Group LLC bought a new position in Viveve Medical during the fourth quarter worth about $32,000. Finally, Geode Capital Management LLC grew its holdings in Viveve Medical by 13.6% during the fourth quarter. Geode Capital Management LLC now owns 216,566 shares of the company’s stock worth $227,000 after purchasing an additional 25,975 shares during the period. Institutional investors and hedge funds own 89.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.watchlistnews.com/viveve-medical-vive-hits-new-12-month-low-at-0-87/2890691.html.

Viveve Medical Company Profile (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

See Also: Earnings Reports

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.